SETDB1 depletion restores the transcriptional status of affected genes back to normal, allowing for cell re-differentiation and cancer cell transformation to normal-like post-miotic cells [94], especially when combined with cytotoxic drugs such as 5-fluorouracil, oxaliplatin and irinotecan. This evidence concerns the gene SETDB1 and cancer.